Filters
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
Press Release, Financial Results
Hikma launches authorised generic of Nucynta® (tapentadol) in the US
Press Release, Product
New
Inspired at Hikma. Meet Ana Santos Perez
Story, Life at Hikma
Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
Story, Life at Hikma
New
Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respect...
Press Release, Product
New
Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment
Press Release, Corporate
New
Exploring partnership opportunities with Hikma Pharmaceuticals. A Q&A with, Faisal Darwazeh VP of Group Business Develop...
Insight, Corporate
New
Hikma announces CEO change and Board appointment
Press Release, Corporate
New
Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy
Story, Leadership
New
European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada
Insight, Corporate
New
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Press Release, Product
New
Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables
Story, Leadership
New
Hikma celebrates 20 years on the London Stock Exchange
Story, Corporate
New
Strategic priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, President Rx and R&D
Insight, Corporate